Clinical outcomes after continuous-flow left ventricular assist device A systematic review

Circulation: Heart Failure

Volumn 7, Issue 6, 2014, Pages 1003-1013

  McIlvennan, Colleen K ^a,d   Magid, Kate H ^b,c   Ambardekar, Amrut V ^a   Thompson, Jocelyn S ^b   Matlock, Daniel D ^a,d   Allen, Larry A ^d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Adult and Child Center for Health Outcomes Research and Delivery Science   (United States)

^c BROWN UNIVERSITY   (United States)

^d Department of Medicine   (United States)

Author keywords

Heart failure; Heart assist devices

Indexed keywords

AORTA VALVE REGURGITATION; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL (TOPIC); CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEVICE FAILURE; DRIVELINE INFECTION; FUNCTIONAL STATUS; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE FAILURE; HOSPITAL READMISSION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; ASSISTED CIRCULATION; HEART ASSIST DEVICE; HEART FAILURE; PROCEDURES; PROSTHESIS; REGISTER; TREATMENT OUTCOME;

ASSISTED CIRCULATION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PROSTHESIS DESIGN; QUALITY OF LIFE; REGISTRIES; TREATMENT OUTCOME;

EID: 84925722274     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001391     Document Type: Article

References (49)

1. Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, Cook NR, Felker GM, Francis GS, Hauptman PJ, Havranek EP, Krumholz HM, Mancini D, Riegel B, Spertus JA; American Heart Association; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125:1928-1952.
2. Beauchamp TL Childress, JF. Principles of Biomedical Ethics. 6th ed. Oxford: Oxford University Press; 2008.
3. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, Arabia F, Bauman ME, Buchholz HW, Deng M, Dickstein ML, El-Banayosy A, Elliot T, Goldstein DJ, Grady KL, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte MP, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov EV, Eduardo Rame J, Russell SD, Sorensen EN, Sun B, Strueber M, Mangi AA, Petty MG, Rogers J; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157-187.
4. Peters, E, Västfjäll, D, Slovic, P, Mertz, CK, Mazzocco, K, Dickert, S. Numeracy and decision making. Psychological Science. 2006;17:408-414.
5. Matlock DD, Nowels CT, Masoudi FA, Sauer WH, Bekelman DB, Main DS, Kutner JS. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34:1634-1644.
6. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
7. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Acker MA, Goldstein DL, Silvestry SC, Milano CA, Timothy Baldwin J, Pinney S, Eduardo Rame J, Miller MA. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12-22.
8. Najjar SS, Slaughter MS, Pagani FD, Starling RC, McGee EC, Eckman P, Tatooles AJ, Moazami N, Kormos RL, Hathaway DR, Najarian KB, Bhat G, Aaronson KD, Boyce SW; HVAD Bridge to Transplant ADVANCE Trial Investigators. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23-34.
9. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst. 2011;103:1436-1443.
10. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators. Use of a continuousflow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.
11. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
12. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
13. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL, Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce SW; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191-3200.
14. Slaughter MS, Pagani FD, McGee EC, Birks EJ, Cotts WG, Gregoric I, Howard Frazier O, Icenogle T, Najjar SS, Boyce SW, Acker MA, John R, Hathaway DR, Najarian KB, Aaronson KD; HeartWare Bridge to Transplant ADVANCE Trial Investigators. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2013;32:675-683.
15. Schmid C, Jurmann M, Birnbaum D, Colombo T, Falk V, Feltrin G, Garatti A, Genoni M, Gerosa G, Göttel P, Gummert J, Halfmann R, Hammel D, Hennig E, Kaufmann F, Lanfranconi M, Meyns B, Mohr F, Müller J, Nikolov D, Rucinskas K, Scheld HH, Schmid FX, Schneider M, Sirvydis V, Tandler R, Vitali E, Vlasselaers D, Weyand M, Wilhelm M, Hetzer R. Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis. J Heart Lung Transplant. 2008;27:253-260.
16. Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K, Strüber M. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg. 2010;37:357-361.
17. Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, Gelijns AC, Hong KN, Teuteberg JJ. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant. 2011;30:402-407.
18. John R, Naka Y, Smedira NG, Starling R, Jorde U, Eckman P, Farrar DJ, Pagani FD. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg. 2011;92:1406-1413.
19. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32:141-156.
20. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20:1016-1024.
21. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS; HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55:1826-1834.
22. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure. Part 2. content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Failure, 1987;198-209.
23. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245-1255.
24. European Quality of Life-5 Dimensions. http://www.euroqual.org. Accessed December 2013.
25. Grady KL, Meyer PM, Mattea A, Dressler D, Ormaza S, White-Williams C, Chillcott S, Kaan A, Loo A, Todd B, Klemme A, Piccione W, Costanzo MR. Change in quality of life from before to after discharge following left ventricular assist device implantation. J Heart Lung Transplant. 2003;22:322-333.
26. Bunte MC, Blackstone EH, Thuita L, Fowler J, Joseph L, Ozaki A, Starling RC, Smedira NG, Mountis MM. Major bleeding during HeartMate II support. J Am Coll Cardiol. 2013;62:2188-2196.
27. Morgan JA, Paone G, Nemeh HW, Henry SE, Patel R, Vavra J, Williams CT, Lanfear DE, Tita C, Brewer RJ. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2012;31:715-718.
28. Goldstein DJ, Naftel D, Holman W, Bellumkonda L, Pamboukian SV, Pagani FD, Kirklin J. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant. 2012;31: 1151-1157.
29. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM; HeartWare Investigators. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57:1375-1382.
30. Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90:1270-1277.
31. Holman WL, Naftel DC, Eckert CE, Kormos RL, Goldstein DJ, Kirklin JK. J Thorac Cardiovasc Surg. 2013;146:437-441.
32. Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33-40.
33. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316-1324.
34. Brenyo A, Rao M, Koneru S, Hallinan W, Shah S, Massey HT, Chen L, Polonsky B, McNitt S, Huang DT, Goldenberg I, Aktas M. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol. 2012;23:515-520.
35. Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, Sheridan BC, Bowen A, Katz JN. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164:373-378.
36. Forest SJ, Bello R, Friedmann P, Casazza D, Nucci C, Shin JJ, D'Alessandro D, Stevens G, Goldstein DJ. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg. 2013;95:1276-1281.
37. Demirozu ZT, Etheridge WB, Radovancevic R, Frazier OH. Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant. 2011;30:182-187.
38. Petrucci RJ, Rogers JG, Blue L. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow ventricular assist device support. J Heart Lung Transplant. 2012;31:27-36.
39. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist devicesupported patients. Circ Heart Fail. 2010;3:668-674.
40. Boothroyd LJ, Lambert LJ, Ducharme A, Guertin JR, Sas G, Charbonneau É, Carrier M, Cecere R, Morin JE, Bogaty P. Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-oflife issues? Circ Cardiovasc Qual Outcomes. 2014;7:179-187.
41. Sudore RL, Schillinger D. Interventions to Improve Care for Patients with Limited Health Literacy. J Clin Outcomes Manag. 2009;16:20-29.
42. McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot". Circ Cardiovasc Qual Outcomes. 2014;7:374-380.
43. Iacovetto M, Matlock DD, McIlvennan CK, Thompson JS, Bradley WJ, Allen LA. Educational resources for patients considering a left ventricular assist device: a cross-sectional review of internet, print, and multimedia materials [published online ahead of print October 14, 2014]. Circ Cardiovasc Qual Outcomes. doi: CIRCOUTCOMES.114.000892. http://circoutcomes.ahajournals.org/content/early/2014/10/14/ CIRCOUTCOMES.114.000892.full.pdf+html.
44. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
45. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN III; INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741-747.
46. Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 2003;9:180-187.
47. Miller LW, Guglin M. Patient selection for ventricular assist devices: a moving target. J Am Coll Cardiol. 2013;61:1209-1221.
48. National Heart, Lung, and Blood Institute. Medical arm of the Interagency Registry for Mechanically Assisted Circulatory Support (MedaMACS). In: ClinicalTrials.gov [Internet]. Bethedsa, MD: National Library of Medicine (US). 2013. https://clinicaltrials.gov/ct2/show/NCT01932294. Accessed April 20, 2014.
49. National Heart, Lung, and Blood Institute, University of Michigan. The evaluation of VAD intervention before inotrope therapy (REVIVEIT). In: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). 2013. http://clinicaltrials.gov/show/NCT01369407 NLM Identifier: NCT01369407. Accessed December 10, 2013.